BetterScholar BetterScholar

E. Puntus

The Lancet, Annals of the Rheumatic Diseases, Proceedings of the International Conference Digital Age: Traditions, Modernity and Innovations
6
Role
Title
Level Year L/R
🐜 Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): a double-blind, multicentre, randomised controlled trial
57 auth. G. Burmester, F. Buttgereit, C. Bernasconi, J. Álvaro-Gracia, Nidia Castro, M. Dougados, C. Gabay, J. Laar, J. Nebesky, A. Pethoe-Schramm, C. Salvarani, M. Donath, M. John, A. Constantin, J. Gottenberg, ... S. Loiseau-Peres, M. Nguyen, T. Schaeverbeke, R. Alten, C. Amberger, W. Biewer, K. Boche, G. Burmester, A. Engel, M. Feuchtenberger, M. Fleck, G. Gauler, B. Heilig, Maria Höhle, C. Iking-Konert, P. Kästner, D. Kofler, K. Krueger, C. Kühne, R. Kurthen, H. Schulze-Koops, H. Schwenke, M. Sieburg, C. Specker, H. Tony, S. Wassenberg, J. Wendler, R. Caporali, O. Epis, M. Matucci-Cerinic, A. Dubikov, R. Kamalova, M. Korolev, V. Mazurov, E. Puntus, N. Damjanov, T. Ilić, M. Lazarevic, S. Milenkovic, M. Petronijevic, E. Bouajina, M. Elleuch 		6 2020
6
🐜
🦁 "Ultimate reality": an institutional phenomenon of the modern era
E. Puntus, T. Pupysheva 		0 2020
0
🦁
🐜 POS0649 EFFICACY AND SAFETY OF LEVILIMAB IN COMBINATION WITH METHOTREXATE IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS: 1-YEAR RESULTS OF PHASE III, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL
25 auth. V. Mazurov, M. Korolev, A. Pristrom, A. Kundzer, N. Soroka, A. Kastanayan, T. Povarova, T. Plaksina, O. Antipova, D. Kretchikova, S. Smakotina, O. Tciupa, E. Puntus, T. Raskina, L. Shilova, ... T. Kropotina, O. Nesmeyanova, T. Popova, I. Vinogradova, I. Linkova, A. Plotnikova, P. Pukhtinskaia, A. Zinkina-Orikhan, A. Eremeeva, A. Lutckii 		0 2022
0
🐜
🦁 Attitudess of Pragmatism in the System of Values of Modern Kazakh Youth: On the Results of Data of a Complex Sociological Research
E. Puntus, T. Pupysheva, E. Esengarayev, A. Taubayev, Y. Goryacheva, B. Kadirov 		0 2020
0
🦁